重症药疹患者1例治疗与护理体会
Treatment and Nursing Experience of 1 Patient with Severe Drug Eruption
DOI: 10.12677/acm.2025.1592628, PDF,   
作者: 刘华丽, 孙燕茹*：山东大学齐鲁医院德州医院，山东 德州；任义云：天津市中医药研究院附属医院，天津
关键词: 重症药疹；护理；治疗；Severe Drug Eruption； Nursing； Treat
摘要: 总结1例重症药疹患者的临床护理经验。制定对患者治疗起到积极作用的护理方案与计划，预防了并发症发生并促进患者康复。
Abstract: The paper summarizes the clinical nursing experience of one patient with severe drug eruption, and develops care plans and plans that have a positive effect on the patient’s treatment prevent complications and promote the patient’s recovery.
文章引用：刘华丽, 任义云, 孙燕茹. 重症药疹患者1例治疗与护理体会[J]. 临床医学进展, 2025, 15(9): 1333-1338. https://doi.org/10.12677/acm.2025.1592628

参考文献

[1] 赵辨. 中国临床皮肤病学[M]. 第2版. 南京: 江苏科学技术出版社, 2017: 794-800.
[2] Stolz, W. (1995) Severe Erythema Anulare Centrifugum-Like Psoriatic Drug Eruption Induced by Terbinafine. Archives of Dermatology, 131, 960-961. [Google Scholar] [CrossRef] 
[3] Syed, Y.Y. (2018) Anlotinib: First Global Approval. Drugs, 78, 1057-1062. [Google Scholar] [CrossRef] [PubMed]
[4] Fang, Y., Su, N., Zou, Q., Cao, Y., Xia, Y., Tang, L., et al. (2023) Anlotinib as a Third-Line or Further Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Single-Arm, Phase 2 Clinical Trial. BMC Medicine, 21, Article No. 423. [Google Scholar] [CrossRef] [PubMed]
[5] Shen, G., Zheng, F., Ren, D., Du, F., Dong, Q., Wang, Z., et al. (2018) Anlotinib: A Novel Multi-Targeting Tyrosine Kinase Inhibitor in Clinical Development. Journal of Hematology & Oncology, 11, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, J., Zhou, Q., Li, S., Ling, R., Zhao, Y., Chen, D., et al. (2024) Metabolic Reprogramming Driven by METTL1-Mediated tRNA m7G Modification Promotes Acquired Anlotinib Resistance in Oral Squamous Cell Carcinoma. Translational Research, 268, 28-39. [Google Scholar] [CrossRef] [PubMed]
[7] Chambers, A., Kundranda, M., Rao, S., Mahmoud, F. and Niu, J. (2021) Anti-Angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors. Current Oncology Reports, 23, Article No. 100. [Google Scholar] [CrossRef] [PubMed]
[8] Liang, L., Hui, K., Hu, C., Wen, Y. and Jiang, X. (2019) Autophagy Inhibition Potentiates the Anti-Angiogenic Property of Multikinase Inhibitor Anlotinib through JAK2/STAT3/VEGFA Signaling in Non-Small Cell Lung Cancer Cells. Annals of Oncology, 30, ii4. [Google Scholar] [CrossRef] 
[9] Li, M.S.C., Mok, K.K.S. and Mok, T.S.K. (2023) Developments in Targeted Therapy & Immunotherapy—How Non-Small Cell Lung Cancer Management Will Change in the Next Decade: A Narrative Review. Annals of Translational Medicine, 11, Article 358. [Google Scholar] [CrossRef] [PubMed]
[10] 武阳, 陆翰杰, 水会锋. 既往免疫经治的晚期非小细胞肺癌患者接受安罗替尼联合PD-1单抗的疗效及安全性[J]. 实用医学杂志, 2023, 39(5): 572-578.
[11] Han, C., Ye, S., Hu, C., Shen, L., Qin, Q., Bai, Y., et al. (2021) Clinical Activity and Safety of Penpulimab (Anti-Pd-1) with Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203). Frontiers in Oncology, 11, Article 684867. [Google Scholar] [CrossRef] [PubMed]
[12] Haddad, C., Sidoroff, A., Kardaun, S.H., Mockenhaupt, M., Creamer, D., Dunant, A., et al. (2013) Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Are Drug Dictionaries Correctly Informing Physicians Regarding the Risk? Drug Safety, 36, 681-686. [Google Scholar] [CrossRef] [PubMed]
[13] 肖汀. 对重症多形红斑/中毒性表皮坏死松解型药疹诊疗指南及临床路径的理解和体会[C]//中华医学会, 中华医学会皮肤性病学分会. 中华医学会第16次全国皮肤性病学术年会摘要集. 2010: 248.
[14] 李铁男, 刘岩. 重症药疹治疗方面的感悟和思考[C]//中国中西医结合学会皮肤性病专业委员会. 2011全国中西医结合皮肤性病学术会议论文汇编. 2011: 43.
[15] 王莹, 郭丽英, 田娜. 1例重症大疱性表皮松解坏死型药疹患者的护理体会[J]. 中国医科大学学报, 2014, 43(8): 761-763.

为你推荐